Company Data
AN2 Therapeutics Inc.
Ticker
ANTX
Current Price
$1.19 -1.65%
Market Cap
$35.9M
Price Target
Refer to Report
Volume
43.8K
52wk Range
$0.87 - $3.07
Overview
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.